13D Filing: VenBio Select Advisor and Immunomedics Inc (IMMU)

Page 5 of 7 – SEC Filing

Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
Item 6 of the Schedule 13D is hereby amended and supplemented by the addition of the following:

The Reporting Persons beneficially own 8,750 call options with a
strike price of $7, which expire on February 16, 2018, for a total of 875,000 shares of Common Stock.

The Reporting Persons have sold 8,750 put options with a strike
price of $7, which expire on February 16, 2018, for a total of 875,000 shares of Common Stock.

Follow Immunomedics Inc (NASDAQ:IMMU)